Insurance patients come to hospital completely unaware about their insurance benefits and restrictions.
Hospitals want insurance patients. That is why they invest years of effort to gain empanelment with insurers or third party administrators (TPA). They complain when an insurer doesn't empanel them. Hospitals are also willing to block their working capital and receive payments for cashless after a month or so. Such is the hunger for insurance or TPA business. So what happens when finally such a prized business comes to the hospital?
Current cashless process
At the time of admission, patient or their representative is asked to make a choice for the treatment package and room category. Once the selection is made, they sign on a pre-authorisation form to be sent to insurance company for approval. The patient is assigned a bed, and depending on complexity of case, it may take 2-24 hours to get pre-auth approval. Patient takes the treatment and on the day of discharge, all medical records are sent to insurance company for final approval. Mostly the claim gets approved for a certain amount, but in a few cases, the cashless claim gets rejected. The IRDAI (Insurance Regulatory and Development Authority of India) data suggests one in 15 cashless claims is rejected. Even in case of approved claims, patients may end up paying substantial amounts out of-pocket because of several reasons, some of which are –
Copayment clause
Chosen room category is more expensive than the one allowed as per insurance policy
Treatment-specific capping
Sum insured limit exhausted
Patient experience
この記事は Healthcare Radius の May 2018 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Healthcare Radius の May 2018 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.